Please use this identifier to cite or link to this item: http://repository.unisma.ac.id/handle/123456789/2037
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLee, Meng-Luen-
dc.contributor.authorSulistyowati, Erna-
dc.contributor.authorHsu, Jong-Hau-
dc.contributor.authorHuang, Bo-Yau-
dc.contributor.authorDai, Zen-Kong-
dc.contributor.authorWu, Bin-Nan-
dc.contributor.authorChao, Yu-Ying-
dc.contributor.authorYeh, Jwu-Lai-
dc.date.accessioned2021-10-14T01:53:14Z-
dc.date.available2021-10-14T01:53:14Z-
dc.date.issued2019-04-08-
dc.identifier.issn1420-3049-
dc.identifier.urihttps://www.mdpi.com/1420-3049/24/7/1376/htm-
dc.identifier.urihttp://repository.unisma.ac.id/handle/123456789/2037-
dc.description[ARCHIVES] Copyright Article from: MDPI journalsen_US
dc.description.abstractTo test whether KMUP-1 (7-[2-[4-(2-chlorophenyl) piperazinyl]ethyl]-1,3-dimethylxanthine) prevents myocardial ischemia-induced apoptosis, we examined KMUP-1-treated H9c2 cells culture. Recent attention has focused on the activation of nitric oxide (NO)-guanosine 3’, 5’cyclic monophosphate (cGMP)-protein kinase G (PKG) signaling pathway triggered by mitogen-activated protein kinase (MAPK) family, including extracellular-signal regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 in the mechanism of cardiac protection during ischemia-induced cell-death. We propose that KMUP-1 inhibits ischemia-induced apoptosis in H9c2 cells culture through these pathways. Cell viability was assessed using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and apoptotic evaluation was conducted using DNA ladder assay and Hoechst 33342 staining. The level of intracellular calcium was detected using-Fura2-acetoxymethyl (Fura2-AM) staining, and mitochondrial calcium with Rhod 2-acetoxymethyl (Rhod 2-AM) staining under fluorescence microscopic observation. The expression of endothelium NO synthase (eNOS), inducible NO synthase (iNOS), soluble guanylate cyclase α1 (sGCα1), PKG, Bcl-2/Bax ratio, ERK1/2, p38, and JNK proteins were measured by Western blotting assay. KMUP-1 pretreatment improved cell viability and inhibited ischemia-induced apoptosis of H9c2 cells. Calcium overload both in the intracellular and mitochondrial sites was attenuated by KMUP-1 pretreatment. Moreover, KMUP-1 reduced intracellular reactive oxygen species (ROS), increased plasma NOx (nitrite and nitrate) level, and the expression of eNOS. Otherwise, the iNOS expression was downregulated. KMUP-1 pretreatment upregulated the expression of sGCα1 and PKG protein. The ratio of Bcl-2/Bax expression was increased by the elevated level of Bcl2 and decreased level of Bax. In comparison with the ischemia group, KMUP-1 pretreatment groups reduced the expression of phosphorylated extracellular signal-regulated kinases ERK1/2, p-p38, and p-JNK as well. Therefore, KMUP-1 inhibits myocardial ischemia-induced apoptosis by restoration of cellular calcium influx through the mechanism of NO-cGMP-MAPK pathways.en_US
dc.language.isoenen_US
dc.publisherMDPI journalsen_US
dc.relation.ispartofseriesMDPI journals;Vol.24, Issue 7, Page 1-15-
dc.subjectKMUP-1en_US
dc.subjectCardiomyocyte Apoptosisen_US
dc.subjectHypoxiaen_US
dc.subjectNitric Oxideen_US
dc.titleKMUP-1 Ameliorates Ischemia-Induced Cardiomyocyte Apoptosis through the NO–cGMP–MAPK Signaling Pathwaysen_US
dc.typeArticleen_US
Appears in Collections:LP - Medical Education

Files in This Item:
File Description SizeFormat 
dr. Erna-6- molecules-24-01376-v3.pdfDocument3.2 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.